Tsang Teresa S M, Enriquez-Sarano Maurice, Freeman William K, Barnes Marion E, Sinak Lawrence J, Gersh Bernard J, Bailey Kent R, Seward James B
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Mayo Clin Proc. 2002 May;77(5):429-36. doi: 10.4065/77.5.429.
To evaluate consecutive therapeutic echocardiographically (echo)-guided pericardiocenteses performed at Mayo Clinic, Rochester, Minn, from 1979 to 2000 and to determine whether patient profiles, practice patterns, and outcomes have changed over time.
Consecutive echo-guided pericardiocenteses performed between February 1, 1979, and January 31, 2000, for treatment of clinically significant pericardial effusions were identified in the Mayo Clinic Echocardiographic-guided Pericardiocentesis Registry. The medical records of these patients were examined, and a follow-up survey was conducted. Clinical profiles, echocardiographic findings, procedural details, and outcomes were determined for 3 periods: February 1, 1979, through January 31, 1986; February 1, 1986, through January 31, 1993; and February 1, 1993, through January 31, 2000.
During the 21-year study period, 1127 therapeutic echo-guided pericardiocenteses were performed in 977 patients. The mean +/- SD age at pericardiocentesis increased from 49+/-14 years in period 1 to 57+/-14 years in period 3. In recent years, cardiothoracic surgery replaced malignancy as the leading cause of an effusion requiring pericardiocentesis and together with malignancy and perforation from catheter-based procedures accounted for nearly 70% of all pericardiocenteses performed. The procedural success rate was 97% overall, with a total complication rate of 4.7% (major, 1.2%; minor, 3.5%). These rates did not change significantly over time. The use of a pericardial catheter for extended drainage increased from 23% in period 1 to 75% in period 3 (P<.001), whereas rates of effusion recurrence and pericardial surgery decreased significantly (P<.001).
The profile of patients presenting with clinically significant pericardial effusion has changed over time. Increasing numbers of older patients and those who have undergone cardiothoracic surgery or catheter-based procedures develop effusions that can be rapidly, safely, and effectively managed with echo-guided pericardiocentesis. Extended drainage with use of a pericardial catheter has become standard practice, and concomitantly, recurrence rates and need for surgical management have decreased considerably.
评估1979年至2000年在明尼苏达州罗切斯特市梅奥诊所连续进行的经治疗性超声心动图(超声)引导的心包穿刺术,并确定患者特征、实践模式和结果是否随时间发生了变化。
在梅奥诊所超声心动图引导心包穿刺术登记处中,识别出1979年2月1日至2000年1月31日期间为治疗具有临床意义的心包积液而连续进行的超声引导心包穿刺术。检查了这些患者的病历,并进行了随访调查。确定了三个时间段的临床特征、超声心动图检查结果、操作细节和结果:1979年2月1日至1986年1月31日;1986年2月1日至1993年1月31日;1993年2月1日至2000年1月31日。
在21年的研究期间,对977例患者进行了1127次经治疗性超声引导的心包穿刺术。心包穿刺时的平均年龄±标准差从第1阶段的49±14岁增加到第3阶段的57±14岁。近年来,心胸外科手术取代恶性肿瘤成为需要心包穿刺术的积液的主要原因,与恶性肿瘤和基于导管操作的穿孔一起占所有心包穿刺术的近70%。总体操作成功率为97%,总并发症发生率为4.7%(严重并发症,1.2%;轻微并发症,3.5%)。这些发生率随时间没有显著变化。心包导管用于延长引流的比例从第1阶段的23%增加到第3阶段的75%(P<0.001),而积液复发率和心包手术率显著下降(P<0.001)。
具有临床意义的心包积液患者的特征随时间发生了变化。越来越多的老年患者以及接受过心胸外科手术或基于导管操作的患者出现积液,这些积液可以通过超声引导心包穿刺术快速、安全且有效地进行处理。使用心包导管进行延长引流已成为标准操作,同时,复发率和手术治疗需求已大幅下降。